Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Elton John AIDS Foundation expands The Rocket Fund to $200 million

This image opens in the lightbox

News provided by

Elton John AIDS Foundation

30 Sep, 2025, 14:43 GMT

Share this article

Share toX

Share this article

Share toX

The bold goal addresses critical gaps as global AIDS funding faces unprecedented cuts

NEW YORK, Sept. 30, 2025 /PRNewswire/ -- The Elton John AIDS Foundation today announced an ambitious expansion of The Rocket Fund, raising its campaign goal to $200 million to accelerate transformative HIV solutions for marginalized communities. The expanded funding will close critical gaps left by global cuts and tackle the stigma that continues to block access to lifesaving care.

Continue Reading
This image opens in the lightbox
Since 2020, we’ve reached 2.2 million people with lifesaving care - but global funding cuts and rising stigma are putting lives at risk. Now is the time to make sure no one is left behind.

"I established the Foundation when the end of AIDS seemed impossible — many would not even say the word. Resources were scarce, but many brave, passionate people made the world take notice," said Elton John, Founder of the Elton John AIDS Foundation. "Today, we stand together on the brink of ending this epidemic, and we won't waste that opportunity. We are doubling down and extending the goal of our Rocket Fund to $200 million to make sure we continue to fuel the momentum that will bring us to the end of AIDS for good."

The need for increased funding is urgent. Despite great scientific advances in HIV prevention, there were still 1.3 million new infections in 2024, including an average of 570 new infections every day among young women aged 15–24. Even before global cuts occurred, 9.2 million people living with HIV weren't accessing treatment, and someone died of AIDS-related causes every minute. In the United States, the epidemic continues to disproportionately impact the U.S. South, which has the highest rates of new HIV diagnoses.

"The 2.2 million people we've reached through The Rocket Fund so far represent more than statistics; they represent mothers, children, partners, and dreamers whose lives have been transformed," said David Furnish, Chair of the Elton John AIDS Foundation. "As global funding faces drastic cuts, our momentum only accelerates to end AIDS for everyone, everywhere. The expansion of The Rocket Fund will serve as a catalyst for this mission." 

Rooted in its mission to lead with compassion and humanity, the Foundation will continue to support bold approaches to reduce new HIV infections and ensure people receive the treatment they deserve. Through The Rocket Fund expansion, the Foundation will invest in rolling out long-acting injectable PrEP (lenacapavir) to communities most in need. In partnership with the Global Fund, the Foundation will begin initial support across Kenya, Nigeria, Uganda, and South Africa.

Anne Aslett, CEO of the Elton John AIDS Foundation, commented: "When we launched the Rocket Fund in 2020, our aim was to accelerate progress toward ending AIDS. Over the last five years, we've done that: doubling our reach in 2024 alone and bringing innovative solutions to millions through our programs — for example, using drone technology to deliver testing and treatment to young people, expanding access to PrEP, and providing humanitarian support for people in Ukraine. Now, as global funding faces unprecedented challenges, we are focused on preserving lifesaving gains; ensuring the HIV response remains a core part of public health and pioneering ambitious new approaches that can bring us closer to an AIDS-free future."

Together with its partners, The Rocket Fund has reached more than 2.2 million people, including over 645,000 young people, with HIV testing, prevention, information, and care. Through 237 grants across 63 countries, The Rocket Fund and its partners have:

  • Tested over 834,000 people for HIV, with a further 467,000 self-test kits distributed.
  • Initiated over 78,000 people on antiretroviral therapy (ART).
  • Initiated over 53,000 people on pre-exposure prophylaxis (PrEP).
  • Connected over 43,000 people to a mental health service.
  • Trained over 36,000 change agents and providers to improve the quality of, and access to, care for people who need it most.

Donatella Versace, Co-Chair of The Rocket Fund, said: "The Elton John AIDS Foundation has always championed young people and vulnerable communities to be able to live their lives with the compassion and justice they deserve. I'm proud to support the lifesaving work of the fund and its expansion to continue the much-needed support for our dear friends around the world."

Elton John and the Elton John AIDS Foundation would like to thank the co-chairs of The Rocket Fund for their contributions to the Foundation and today's announcement, including Donatella Versace, Tani Austin, David Furnish, and David Geffen. The Foundation would also like to thank the Founding Partners of The Rocket Fund:  A+E Networks, Charlotte Tilbury, David Geffen Foundation, Ford Foundation, Gilead Sciences, Inc., Saks Fifth Avenue, Allegra Versace Beck, and The Versace Foundation. 

About the Elton John AIDS Foundation 

The Elton John AIDS Foundation was established in 1992 and is one of the leading independent AIDS organizations in the world. The Foundation's mission is simple: an end to the AIDS epidemic. The Elton John AIDS Foundation is committed to overcoming the stigma, discrimination and neglect that keep us from ending AIDS. With the mobilization of our network of generous supporters and partners, we fund local experts across four continents to challenge discrimination, prevent infections and provide treatment, as well as informing government strategies to end AIDS.

www.eltonjohnaidsfoundation.org. @ejaf on Instagram.

Media Contact:
Deanna Jhaveri | deanna.jhaveri@eltonjohnaidsfoundation.org

Video - https://mma.prnewswire.com/media/2785892/19291_EJAF_Rocket_Fund_YT_DONATE_NOW.mp4
Logo - https://mma.prnewswire.com/media/2785257/Elton_John_AIDS_Foundation_Logo.jpg

Modal title

Also from this source

Elton John AIDS Foundation launches pilot schemes to accelerate access to Pre-Exposure Prophylaxis (PrEP) and reduce new HIV transmissions in England

Elton John AIDS Foundation launches pilot schemes to accelerate access to Pre-Exposure Prophylaxis (PrEP) and reduce new HIV transmissions in England

The Elton John AIDS Foundation, together with Fast-Track Cities, Gilead Sciences and ViiV Healthcare, is investing over £1 million in two innovation...

Elton John AIDS Foundation welcomes Tobias Hestler, Henry R. Muñoz III, and Joshua Schulman to its Board of Directors

Elton John AIDS Foundation welcomes Tobias Hestler, Henry R. Muñoz III, and Joshua Schulman to its Board of Directors

The Elton John AIDS Foundation is delighted to announce the appointment of three new members to its Board of Directors - Tobias Hestler, Henry R....

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Lesbian, Gay & Bisexual

Lesbian, Gay & Bisexual

Diversity, Equity & Inclusion

Diversity, Equity & Inclusion

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.